These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
448 related articles for article (PubMed ID: 19118607)
1. Catalytic activity-independent pathway is involved in phospholipase A(2)-induced apoptotic death of human leukemia U937 cells via Ca(2+)-mediated p38 MAPK activation and mitochondrial depolarization. Liu WH; Kao PH; Chiou YL; Lin SR; Wu MJ; Chang LS Toxicol Lett; 2009 Mar; 185(2):102-9. PubMed ID: 19118607 [TBL] [Abstract][Full Text] [Related]
2. ROS-mediated p38alpha MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A(2)-treated U937 cells. Liu WH; Cheng YC; Chang LS J Cell Physiol; 2009 Jun; 219(3):642-51. PubMed ID: 19180563 [TBL] [Abstract][Full Text] [Related]
3. Taiwan cobra phospholipase A2-elicited JNK activation is responsible for autocrine fas-mediated cell death and modulating Bcl-2 and Bax protein expression in human leukemia K562 cells. Chen KC; Liu WH; Chang LS J Cell Biochem; 2010 Jan; 109(1):245-54. PubMed ID: 19937732 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of Fas and FasL in Taiwan cobra phospholipase A2-treated human neuroblastoma SK-N-SH cells through ROS- and Ca2+-mediated p38 MAPK activation. Chen KC; Kao PH; Lin SR; Chang LS J Cell Biochem; 2009 Jan; 106(1):93-102. PubMed ID: 19009558 [TBL] [Abstract][Full Text] [Related]
5. Arachidonic acid-induced apoptosis of human neuroblastoma SK-N-SH cells is mediated through mitochondrial alteration elicited by ROS and Ca(2+)-evoked activation of p38alpha MAPK and JNK1. Chen KC; Chang LS Toxicology; 2009 Aug; 262(3):199-206. PubMed ID: 19540902 [TBL] [Abstract][Full Text] [Related]
6. Arachidonic acid induces Fas and FasL upregulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-Fos pathway and activation of p38 MAPK/ATF-2 pathway. Liu WH; Chang LS Toxicol Lett; 2009 Dec; 191(2-3):140-8. PubMed ID: 19720122 [TBL] [Abstract][Full Text] [Related]
7. JNK1/c-Jun and p38 alpha MAPK/ATF-2 pathways are responsible for upregulation of Fas/FasL in human chronic myeloid leukemia K562 cells upon exposure to Taiwan cobra phospholipase A2. Chen KC; Chiou YL; Chang LS J Cell Biochem; 2009 Oct; 108(3):612-20. PubMed ID: 19670268 [TBL] [Abstract][Full Text] [Related]
8. Naja nigricollis CMS-9 enhances the mitochondria-mediated death pathway in adaphostin-treated human leukaemia U937 cells. Chen YJ; Wang JJ; Chang LS Clin Exp Pharmacol Physiol; 2011 Nov; 38(11):755-63. PubMed ID: 21824174 [TBL] [Abstract][Full Text] [Related]
9. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells. Kang YH; Lee SJ J Cell Physiol; 2008 Oct; 217(1):23-33. PubMed ID: 18412143 [TBL] [Abstract][Full Text] [Related]
10. Involvement of p38 MAPK- and JNK-modulated expression of Bcl-2 and Bax in Naja nigricollis CMS-9-induced apoptosis of human leukemia K562 cells. Chen YJ; Liu WH; Kao PH; Wang JJ; Chang LS Toxicon; 2010 Jun; 55(7):1306-16. PubMed ID: 20144638 [TBL] [Abstract][Full Text] [Related]
11. Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-fos pathway and activation of p38 MAPK/c-jun pathway. Liu WH; Chang LS J Cell Physiol; 2010 Sep; 224(3):775-85. PubMed ID: 20432471 [TBL] [Abstract][Full Text] [Related]
12. Suppression of ERK signaling evokes autocrine Fas-mediated death in arachidonic acid-treated human chronic myeloid leukemia K562 cells. Chen KC; Liu WH; Chang LS J Cell Physiol; 2010 Mar; 222(3):625-34. PubMed ID: 19927299 [TBL] [Abstract][Full Text] [Related]
13. N,N-dimethyl phytosphingosine induces caspase-8-dependent cytochrome c release and apoptosis through ROS generation in human leukemia cells. Kim BM; Choi YJ; Han Y; Yun YS; Hong SH Toxicol Appl Pharmacol; 2009 Aug; 239(1):87-97. PubMed ID: 19481559 [TBL] [Abstract][Full Text] [Related]
14. Desipramine-induced Ca-independent apoptosis in Mg63 human osteosarcoma cells: dependence on P38 mitogen-activated protein kinase-regulated activation of caspase 3. Lu T; Huang CC; Lu YC; Lin KL; Liu SI; Wang BW; Chang PM; Chen IS; Chen SS; Tsai JY; Chou CT; Jan CR Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):297-303. PubMed ID: 18986328 [TBL] [Abstract][Full Text] [Related]
15. Apoptosis induced by 2-acetyl-3-(6-methoxybenzothiazo)-2-yl-amino-acrylonitrile in human leukemia cells involves ROS-mitochondrial mediated death signaling and activation of p38 MAPK. Repicky A; Jantova S; Cipak L Cancer Lett; 2009 May; 277(1):55-63. PubMed ID: 19108948 [TBL] [Abstract][Full Text] [Related]
16. Kalopanaxsaponin A induces apoptosis in human leukemia U937 cells through extracellular Ca2+ influx and caspase-8 dependent pathways. Choi JH; Lee HW; Park HJ; Kim SH; Lee KT Food Chem Toxicol; 2008 Nov; 46(11):3486-92. PubMed ID: 18804143 [TBL] [Abstract][Full Text] [Related]
17. Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade. Mandal C; Dutta A; Mallick A; Chandra S; Misra L; Sangwan RS; Mandal C Apoptosis; 2008 Dec; 13(12):1450-64. PubMed ID: 18987975 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis induced by protein phosphatase 2A (PP2A) inhibition in T leukemia cells is negatively regulated by PP2A-associated p38 mitogen-activated protein kinase. Boudreau RT; Conrad DM; Hoskin DW Cell Signal; 2007 Jan; 19(1):139-51. PubMed ID: 16844342 [TBL] [Abstract][Full Text] [Related]
19. p38 MAPK activation and mitochondrial depolarization mediate the cytotoxicity of Taiwan cobra phospholipase A2 on human neuroblastoma SK-N-SH cells. Chen KC; Kao PH; Lin SR; Chang LS Toxicol Lett; 2008 Jul; 180(1):53-8. PubMed ID: 18582542 [TBL] [Abstract][Full Text] [Related]
20. Modulation of gold(III) porphyrin 1a-induced apoptosis by mitogen-activated protein kinase signaling pathways. Wang Y; He QY; Che CM; Tsao SW; Sun RW; Chiu JF Biochem Pharmacol; 2008 Mar; 75(6):1282-91. PubMed ID: 18241839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]